Company intelligence / Profile preview

Tierra Biosciences

South San Francisco, California, USA

Ownership: Private
Development stage: Other

Overview

Tierra Biosciences is a synthetic biology technology provider that offers an AI-powered, cell-free protein synthesis and screening platform. The company does not develop therapeutics but instead provides services to generate and characterize proteins, including difficult-to-express varieties, for diverse clients in pharma, biotech, agriculture, and other industries. They focus on enabling research and accelerating protein engineering rather than clinical drug development.

Modalities: ProteinRecombinant proteinCell-free synthesized protein
Industry: Non-Drug Biotech

Partnerships

Caltech (technology origin)DARPAPharmaceutical, biotech, and agriculture clients (various undisclosed)[3][5]

Beyond the preview

Go deeper on Tierra Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tierra Biosciences.

Explore the full profile